blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4146186

EP4146186 - COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS PRODUCTION OF HYDROGEN SULFIDE (H2S) [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  10.02.2023
Database last updated on 02.08.2024
FormerThe international publication has been made
Status updated on  12.11.2021
Formerunknown
Status updated on  05.05.2021
Most recent event   Tooltip27.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Parthenogen SAGL
Piazza Indipendenza, 11
6900 Lugano / CH
[2023/11]
Inventor(s)01 / DATTILO, Maurizio
6926 Montagnola / CH
 [2023/11]
Representative(s)Dragotti & Associati S.R.L.
Via Nino Bixio, 7
20129 Milano / IT
[N/P]
Former [2023/11]Sonzogni, Laura Gabriella, et al
Dragotti & Associati S.r.l.
Via Nino Bixio, 7
20129 Milano / IT
Application number, filing date21721572.203.05.2021
[2023/11]
WO2021EP61509
Priority number, dateIT2020000970004.05.2020         Original published format: IT202000009700
[2023/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021224153
Date:11.11.2021
Language:EN
[2021/45]
Type: A1 Application with search report 
No.:EP4146186
Date:15.03.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 11.11.2021 takes the place of the publication of the European patent application.
[2023/11]
Search report(s)International search report - published on:EP11.11.2021
ClassificationIPC:A61K31/185, A61K31/198, A61K31/4415, A61P3/10, A61P9/00, A61P9/04, A61P9/10, A61P9/12, A61P15/08, A61P15/10, A61P17/06, A61P25/16, A61P25/28, A61P31/12, A61P35/00, A61P37/00, A61P37/06
[2023/11]
CPC:
A61K31/198 (EP,US); A61K31/675 (US); A61K31/145 (US);
A61K31/185 (EP); A61K31/4415 (EP,US); A61K9/0053 (US);
A61K9/2009 (US); A61K9/2013 (US); A61K9/2054 (US);
A61P15/08 (EP,US); A61P15/10 (EP); A61P17/06 (EP);
A61P25/16 (EP); A61P25/28 (EP,US); A61P3/10 (EP,US);
A61P31/12 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/06 (EP,US); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP,US); A61P9/14 (US) (-)
C-Set:
A61K31/185, A61K2300/00 (EP);
A61K31/198, A61K2300/00 (EP);
A61K31/4415, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/11]
TitleGerman:KOMBINATION VON MIKRONÄHRSTOFFEN ZUR STIMULIERUNG DER ENDOGENEN PRODUKTION VON SCHWEFELWASSERSTOFF (H2S)[2023/11]
English:COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS PRODUCTION OF HYDROGEN SULFIDE (H2S)[2023/11]
French:COMBINAISON DE MICRONUTRIMENTS POUR STIMULER LA PRODUCTION ENDOGÈNE DE SULFURE D'HYDROGÈNE (H2S)[2023/11]
Entry into regional phase14.10.2022National basic fee paid 
14.10.2022Designation fee(s) paid 
14.10.2022Examination fee paid 
Examination procedure14.10.2022Amendment by applicant (claims and/or description)
14.10.2022Examination requested  [2023/11]
14.10.2022Date on which the examining division has become responsible
Fees paidRenewal fee
24.03.2023Renewal fee patent year 03
26.03.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0243507  (HEALTH RES INST [US], et al) [X] 1-13,19,24 * the whole document * * claim 9 *;
 [X]WO2005072749  (HALEVIE GOLDMAN BRIAN D [US]) [X] 1-13,15-17,19,24 * the whole document * * page 3, line 5 - page 5, line 5 * * page 14, line 9 - page 17, paragraph 20 *;
 [X]US6964969  (MCCLEARY EDWARD LARRY [US]) [X] 1-13,19-24 * the whole document * * column 19, line 38 - column 20, line 33 *;
 [X]IN1334CHE2007  (SRINIVASAN J., GOPALAKRISHNAN K.) [X] 1-13,16 * the whole document ** claim 1; table 1 *;
 [X]DE202006013518U  (BIEGER WILFRIED P [DE]) [X] 1-13,19 * example 8 * * the whole document *;
 [XI]WO2007070454  (NOVALIFE [US], et al) [X] 1-14,16,17,24 * the whole document * * examples 2,6,12-16 * [I] 18,21,22;
 [X]WO2007073175  (NUTRICIA NV [NL], et al) [X] 1-13,19,23 * the whole document * * examples 2,4 *;
 [X]US2007166400  (RATH MATTHIAS [ZA], et al) [X] 1,3-13,15 * the whole document * * claims 1,8-10 *;
 [X]US2007286909  (SMITH DANIEL S [US], et al) [X] 1-13,24 * the whole document * * example 1; table 3 *;
 [X]US2007292536  (KELLERMANN GOTTFRIED [US]) [X] 1-13,24 * the whole document * * paragraph [0021] - paragraph [0023] *;
 [X]US2013196429  (ALI BIN M ABUDALLAH JAFFAR [MY]) [X] 1,23 * the whole document * * claims 8,12 *;
 [X]US2014178987  (LIU XIAOQING [CN], et al) [X] 1,23 * the whole document * * claims 1-3 *;
 [X]DE202018101715U  (NEUROFELIX HANDELS GMBH [DE]) [X] 1-13,19 * the whole document * * paragraphs [0147] , [0148]; examples 4-6; claims 1,3,5 *
by applicantCN102078327
 WO2012075242
 US2013253051
 CN103622992
 US2015342969
 US2016058779
 CN106243035
 CN106432123
 US2017216323
    - P. STAHLC. WERMUTH, Handbook of pharmaceutical salts, WILEY-VCH, (20080000), pages 127 - 133
    - ZANARDO et al., FASEB J., (20060000), vol. 20, no. 12, pages 2118 - 20
    - SUN Q et al., Hypertension, (20160300), vol. 67, no. 3, pages 541 - 9
    - LI H et al., J Virol, (20150000), vol. 89, no. 10, pages 5557 - 68
    - BAZHANOV N et al., Sci Rep, (20170000), vol. 7, page 41029
    - KABIL et al., J Biol Chem, (20160000), vol. 291, no. 32, pages 16418 - 16423
    - BILSKA-WILKOSZ A et al., Int J Mol Sci, (20170000), vol. 18, page 1315
    - HU L-F et al., Aging Cell, (20100000), vol. 9, pages 135 - 146
    - VANDINI E et al., Pharmacology, (20190000), vol. 103, pages 50 - 60
    - YANG R et al., Immunity, (20150000), vol. 43, pages 251 - 263
    - WANG J et al., Antiox & Redox Sign, (20180000), vol. 28, no. 16, pages 1447 - 1462
    - SHIRAISHI KNAITO K, Human Reproduction, (20050000), vol. 20, no. 9, pages 2608 - 2613
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.